The Division of Medical Toxicology at Brigham Health was established in January of 2017. The mission of the Division of Medical Toxicology is to provide high quality, expert toxicological consultation services to Partners hospitals and outpatient clinics, develop educational programs for resident, medical students and attending physicians, and conduct innovative research in toxicology and its related comorbidities. The Division is integrated into the Harvard Combined Emergency Medicine Residency as well as the Harvard Medical Toxicology Fellowship. Division members maintain their clinical emergency medicine expertise at BWH and BWFH and see bedside consults at BWH and BWFH. Since its inception, the division of medical toxicology has expanded to include affiliate members at MGH and Boston Children’s hospital.
Fulbright US Scholars (E. Boyer)
Federal funding: R01, K23, K24, DARPA, SBIR
NATO Science for Peace and Security grant, Ukraine (T Erickson)
Countermeasures to CBRN agents and Emerging Technologies: Advanced Training Response to Conflict and Security Challenges in East Ukraine.
Industry funding: United Technologies, Philips, Gilead Sciences
Cross departmental research collaborations: Laboratory Medicine, Informatics and Anesthesia
Over 30 toxicology-related peer-reviewed publications from the Division in 2017-2019
15 Scientific Toxicological national & international meeting abstract presentations
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.